Although human embryonic stem cells (hESC) are promising in cardiovascular regeneration therapy, potential host immune response towards transplanted hESC is not well characterized. We hypothesize that hESC transplantation elicits an adaptive murine immune response that may be modulated by immunosuppressive drugs.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The Journal of Heart and Lung Transplantation
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2008 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.